Literature DB >> 20551764

Metastasectomy for stage IV colorectal cancer.

Najjia Mahmoud1, Kelli Bullard Dunn.   

Abstract

Metastatic colorectal cancer traditionally has been considered incurable. Over the past 3 decades, however, resection of low-volume hepatic disease has been recognized as beneficial in some cases. More recently, resection of isolated pulmonary metastases has been shown to offer long-term survival in carefully selected patients. Resection of metastases to more unusual sites (ovary, brain, peritoneal cavity) is more controversial; nevertheless, retrospective data suggest that a few patients may be cured with resection of these tumors. In this article, we review the history and current status of metastasectomy in stage IV colorectal cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20551764     DOI: 10.1007/DCR.0b013e3181dcadbc

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  27 in total

1.  Identification of patients likely to benefit from metastasectomy in stage IV colorectal cancer.

Authors:  Manabu Shimomura; Masazumi Okajima; Takao Hinoi; Hiroyuki Egi; Yuji Takakura; Yasuo Kawaguchi; Masakazu Tokunaga; Tomohiro Adachi; Hirotaka Tashiro; Hideki Ohdan
Journal:  Int J Colorectal Dis       Date:  2012-03-10       Impact factor: 2.571

2.  Expression of MMP-9 and WAVE3 in colorectal cancer and its relationship to clinicopathological features.

Authors:  Yi Zhang; Xiao-Ya Guan; Bin Dong; Min Zhao; Jian-Hui Wu; Xiu-Yun Tian; Chun-Yi Hao
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-18       Impact factor: 4.553

Review 3.  Radical irradiation of extracranial oligometastases.

Authors:  Joseph K Salama; Michael T Milano
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

Review 4.  The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review.

Authors:  Timothy L Fitzgerald; Jason Brinkley; Shannon Banks; Nasreen Vohra; Zachary P Englert; Emmanuel E Zervos
Journal:  Langenbecks Arch Surg       Date:  2014-08-23       Impact factor: 3.445

5.  Metastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Aaron U Blackham; Gregory B Russell; John H Stewart; Konstantinos Votanopoulos; Edward A Levine; Perry Shen
Journal:  Ann Surg Oncol       Date:  2014-03-11       Impact factor: 5.344

6.  Improved overall survival in head and neck cancer patients after specific therapy of distant metastases.

Authors:  Dominik Schulz; Markus Wirth; Guido Piontek; Andreas Knopf; Christoph Straube; Steffi Pigorsch; Stephanie E Combs; Anja Pickhard
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-08       Impact factor: 2.503

7.  Predictors and outcome of complete removal of colorectal cancer with synchronous lung metastases.

Authors:  Hiroaki Nozawa; Junichiro Tanaka; Takeshi Nishikawa; Toshiaki Tanaka; Tomomichi Kiyomatsu; Kazushige Kawai; Keisuke Hata; Shinsuke Kazama; Hironori Yamaguchi; Soichiro Ishihara; Eiji Sunami; Joji Kitayama; Jun Nakajima; Norihiro Kokudo; Toshiaki Watanabe
Journal:  Mol Clin Oncol       Date:  2015-07-08

8.  Pulmonary Metastasis After Resection of Cholangiocarcinoma: Incidence, Resectability, and Survival.

Authors:  Mihoko Yamada; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Takashi Mizuno; Junpei Yamaguchi; Masato Nagino
Journal:  World J Surg       Date:  2017-06       Impact factor: 3.352

9.  Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases.

Authors:  Giovanni Brandi; Jody Corbelli; Francesco de Rosa; Stefania Di Girolamo; Ciro Longobardi; Valentina Agostini; Ingrid Garajová; Stefano La Rovere; Giorgio Ercolani; Gian Luca Grazi; Antonio Daniele Pinna; Guido Biasco
Journal:  Langenbecks Arch Surg       Date:  2012-06-19       Impact factor: 3.445

10.  microRNA expression profiles in human colorectal cancers with brain metastases.

Authors:  Zhenyang Li; Xiaodong Gu; Yantian Fang; Jianbin Xiang; Zongyou Chen
Journal:  Oncol Lett       Date:  2011-11-29       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.